106 related articles for article (PubMed ID: 9127459)
1. Effect of perindopril therapy on fluidity and potential of erythrocyte membrane from individuals with coronary heart disease.
Piasecka A; Koter M; Buczyński A; Leyko W; Kedziora J; Tkaczewski W; Bryszewska M
Scand J Clin Lab Invest; 1997 Feb; 57(1):65-71. PubMed ID: 9127459
[TBL] [Abstract][Full Text] [Related]
2. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
3. Effects of genistein and daidzein on erythrocyte membrane fluidity: an electron paramagnetic resonance study.
Ajdzanović V; Spasojević I; Filipović B; Sosić-Jurjević B; Sekulić M; Milosević V
Can J Physiol Pharmacol; 2010 Apr; 88(4):497-500. PubMed ID: 20555419
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats.
Lee RM; Lu M; Gillies L; Werstiuk ES
Can J Cardiol; 1997 Sep; 13(9):831-5. PubMed ID: 9343032
[TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
6. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M
Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551
[TBL] [Abstract][Full Text] [Related]
7. [The erythrocyte membrane structure in patients with mixed hyperlipidemia].
Broncel M; Balcerak M; Bała A; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(1-2):4-9. PubMed ID: 17607961
[TBL] [Abstract][Full Text] [Related]
8. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
9. Immobilization-induced changes in erythrocyte membrane fluidity in rabbits: a spin-label electron spin resonance study.
Liu M; Li J; Qin L; Lee KM; Chan KM
Ann Clin Lab Sci; 2002; 32(4):399-403. PubMed ID: 12458893
[TBL] [Abstract][Full Text] [Related]
10. EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.
Simoons ML; Vos J; de Feyter PJ; Bots ML; Remme WJ; Grobbee DE; Kluft C; de Maat MP; Fox KM; Deckers JW
Eur Heart J; 1998 Sep; 19 Suppl J():J56-60. PubMed ID: 9796842
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
Sami M
Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
[TBL] [Abstract][Full Text] [Related]
12. [The protective effects of metallothionein on membrane proteins against endothelin--electron paramagnetic resonance spin labelling study].
Wang G; Hou L; Cheng S; Tang CS; An RS
Sheng Li Xue Bao; 1994 Feb; 46(1):59-64. PubMed ID: 8085169
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
[TBL] [Abstract][Full Text] [Related]
14. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
[TBL] [Abstract][Full Text] [Related]
15. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy.
Yang G; Qiu H; Wang S; Deng H; Zhang S; Li L
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451
[TBL] [Abstract][Full Text] [Related]
16. Electron spin resonance study of the erythrocyte membrane fluidity changes in diabetes.
Preoteasa EA; Ionescu-Tîrgovişte C; Grecu VV; Georgescu R
Rom J Intern Med; 1993; 31(4):271-82. PubMed ID: 8148779
[TBL] [Abstract][Full Text] [Related]
17. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
[TBL] [Abstract][Full Text] [Related]
18. Human red blood cell membrane potential and fluidity in glucose solutions.
Zavodnik IB; Piasecka A; Szosland K; Bryszewska M
Scand J Clin Lab Invest; 1997 Feb; 57(1):59-63. PubMed ID: 9127458
[TBL] [Abstract][Full Text] [Related]
19. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)].
Tereshchenko SN; Kobalova ZhD; Demidova IV; Moiseev VS
Ter Arkh; 1997; 69(12):40-3. PubMed ID: 9503533
[TBL] [Abstract][Full Text] [Related]
20. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
